Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Dow
Mallinckrodt
Argus Health
Boehringer Ingelheim
Moodys
Cipla
Healthtrust
Farmers Insurance
Cantor Fitzgerald

Generated: June 23, 2018

DrugPatentWatch Database Preview

LERITINE Drug Profile

see a sample report or, see our see our flat-rate plans

« Back to Dashboard

When do Leritine patents expire, and when can generic versions of Leritine launch?

Leritine is a drug marketed by Merck and is included in two NDAs.

The generic ingredient in LERITINE is anileridine hydrochloride. Additional details are available on the anileridine hydrochloride profile page.
Summary for LERITINE
Drug patent expirations by year for LERITINE
Synonyms for LERITINE
(+-)-Anileridine hydrochloride
1-(2-(4-Aminophenyl)ethyl)-4-phenyl-4-piperidinecarboxylic acid ethyl ester
1-(2-(4-Aminophenyl)ethyl)-4-phenyl-4-piperidinecarboxylic acid ethyl ester dhydrochloride
1-(2-(4-Aminophenyl)ethyl)-4-phenyl-4-piperidinecarboxylic acid ethyl ester hydrochloride
1-(p-Aminophenethyl)-4-phenylisonipecotic acid ethyl ester
1-(p-Aminophenethyl)-4-phenylisonipecotic acid, ethyl ester, dihydrochloride
1-(p-Aminophenethyl)-4-phenylpiperidine-4-carboxylic acid ethyl ester
1-(p-Aminophenethyl)-4-phenylpiperidine-4-carboxylic acid ethyl ester dihydrochloride
1-[2-(4-Aminophenyl)ethyl]-4-phenyl-4-piperidinecarboxlic acid ethyl ester
1-[2-(4-ammoniophenyl)ethyl]-4-(ethoxycarbonyl)-4-phenylpiperidinium dichloride
126-12-5
126-12-5 (di-hydrochloride)
144-14-9
144-14-9 (Parent)
4-Piperidinecarboxylic acid, 1-(2-(4-aminophenyl)ethyl)-4-phenyl-, ethyl ester
4-Piperidinecarboxylic acid, 1-(2-(4-aminophenyl)ethyl)-4-phenyl-, ethyl ester, dihydrochloride
4-Piperidinecarboxylic acid, 1-(2-(4-aminophenyl)ethyl)-4-phenyl-, ethyl ester, monohydrochloride
4-Piperidinecarboxylic acid, 1-[2-(4-aminophenyl)ethyl]-4-phenyl-, ethyl ester
53421-22-0
53421-22-0 (mono-hydrochloride)
71Q1A3O279
77005-EP2275420A1
77005-EP2280008A2
77005-EP2298764A1
77005-EP2298765A1
77005-EP2308509A1
915Q054DLC
AC1L1LFH
AC1L1RZS
AC1L5322
Adopol
AK515754
AKOS027446331
Aldine
Alidine
Anileridina
Anileridina [INN-Spanish]
ANILERIDINE
Anileridine (USP/INN)
Anileridine [INN:BAN]
Anileridine [USP:INN:BAN]
anileridine 2HCl
Anileridine dihydrochloride
Anileridine HCl
Anileridine hydrochloride
Anileridine hydrochloride (USP)
Anileridine hydrochloride [USP]
anileridine monohydrochloride
Anileridinum
Anileridinum [INN-Latin]
API0004762
Apidol
Apodol
CAS-144-14-9
CHEBI:61203
CHEBI:61208
CHEMBL1201047
CHEMBL1201347
D02941
D02942
D05ZTJ
D0X6HD
DB00913
DEA No. 9020
DSSTox_CID_2610
DSSTox_GSID_22610
DSSTox_RID_97535
DTXSID50155034
DTXSID70201587
DTXSID8022610
EINECS 204-770-0
Ethyl 1-(2-(4-aminophenyl)ethyl)-4-phenyl-4-piperidinecarboxylate
Ethyl 1-(2-(4-aminophenyl)ethyl)-4-phenylpiperidine-4-carboxylate dihydrochloride
Ethyl 1-(4-aminophenethyl)-4-phenylisonipecotate
Ethyl 1-(4-aminophenethyl)-4-phenylisonipecotate dihydrochloride
Ethyl 1-(4-aminophenethyl)-4-phenylpiperidine-4-carboxylate
Ethyl 1-(p-aminophenethyl)-4-phenylisonipecotate
Ethyl 1-(p-aminophenethyl)-4-phenylisonipecotate dihydrochloride
Ethyl 1-[2-(4-aminophenyl)ethyl]-4-phenyl-4-piperidinecarboxylate #
ethyl 1-[2-(4-aminophenyl)ethyl]-4-phenylpiperidine-4-carbox
ethyl 1-[2-(4-aminophenyl)ethyl]-4-phenylpiperidine-4-carboxylate
ethyl 1-[2-(4-aminophenyl)ethyl]-4-phenylpiperidine-4-carboxylate dihydrochloride
ethyl 1-[2-(4-aminophenyl)ethyl]-4-phenylpiperidine-4-carboxylate hydrochloride
FT-0662219
GTPL7115
HE064040
HE311563
HSDB 3288
Isonipecotic acid, 1-(p-aminophenethyl)-4-phenyl-, ethyl ester
ISONIPECOTIC ACID, 1-(p-AMINOPHENYL)-4-PHENYL-, ETHYL ESTER, DIHYDROCHLORIDE
L000700
Leritin
Leritine (TN)
Leritine dihydrochloride
Leritine|||Nipecotan
LKYQLAWMNBFNJT-UHFFFAOYSA-N
LS-114624
LS-114625
LS-85061
N-(beta-(p-Aminophenyl)ethyl)-4-phenyl-4-carbethoxypiperidine
N-(beta-(p-Aminophenyl)ethyl)-4-phenyl-4-carbethoxypiperidine dihydrochloride
N-beta-(p-Aminophenyl)ethylnormeperidine
N-beta-(p-Aminophenyl)ethylnormeperidine dihydrochloride
NCGC00253613-01
Nipecotan
SCHEMBL119086
SCHEMBL26333
SCHEMBL7119028
Tox21_113744
UNII-71Q1A3O279
UNII-915Q054DLC
ZINC608179

US Patents and Regulatory Information for LERITINE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Merck LERITINE anileridine phosphate INJECTABLE;INJECTION 010520-003 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Merck LERITINE anileridine hydrochloride TABLET;ORAL 010585-002 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

see a sample report or, see our see our flat-rate plans

see a sample report or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Chubb
Boehringer Ingelheim
Accenture
Citi
Johnson and Johnson
Medtronic
Express Scripts
Colorcon
Daiichi Sankyo

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.